I was just looking at exel's news out today in their current trial 9 out of 24 had AE's stock down 13 per cent man that stock was the best performer in biotech ytd without a buyout, things happen fast in bio, good and bad. when to sell here is going to be a tough one to gage. don't want to get caught like 2013, don't want to miss a big payday either. back in February a lot of us would have taken 12.00 and be happy, except for vid and jess that is, but now its all changed. I'm not ready to sell yet, but I'm not waiting for a parade down landsdown street either!
